Cardiff Oncology, Inc. (CRDF)
1.90
+0.06
(+3.26%)
USD |
NASDAQ |
May 29, 16:00
1.90
0.00 (0.00%)
After-Hours: 20:00
Cardiff Oncology EPS Diluted (Quarterly) : -0.1807 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Ocugen, Inc. | -0.0586 |
| CytomX Therapeutics, Inc. | -0.1029 |
| TuHURA Biosciences, Inc. | -0.1256 |
| ACADIA Pharmaceuticals, Inc. | 0.0211 |
| Alnylam Pharmaceuticals, Inc. | 1.508 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -12.34M |
| Revenue (Quarterly) | 0.041M |
| Total Expenses (Quarterly) | 12.39M |
| Enterprise Value | 84.49M |
| Gross Profit Margin (Quarterly) | -439.0% |
| Profit Margin (Quarterly) | -30.11K% |
| Earnings Yield | -35.01% |
| Normalized Earnings Yield | -35.01 |